ACADIA Pharmaceuticals Ownership | Who Owns ACADIA Pharmaceuticals?


OverviewForecastRevenueFinancialsChartTranscripts

ACADIA Pharmaceuticals Ownership Summary


ACADIA Pharmaceuticals is owned by 100.98% institutional investors, 0.57% insiders. Baker bros. advisors lp is the largest institutional shareholder, holding 25.56% of ACAD shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 4.39% of its assets in ACADIA Pharmaceuticals shares.

ACAD Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockACADIA Pharmaceuticals100.98%0.57%-1.55%
SectorHealthcare Stocks 488.17%11.08%-399.26%
IndustryBiotech Stocks 306.59%11.10%-217.69%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Baker bros. advisors lp42.90M25.56%$925.28M
Blackrock funding, inc. /de20.65M12.31%$445.47M
Vanguard group13.95M8.40%$255.94M
Blackrock12.06M7.32%$196.01M
Rtw investments, lp9.00M5.36%$194.03M
State street4.52M2.72%$82.97M
D. e. shaw3.24M1.95%$59.48M
Point72 asset management3.17M1.89%$68.43M
Goldman sachs group2.88M1.74%$52.86M
Geode capital management2.88M1.73%$52.81M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Palo alto investors lp2.56M11.76%$55.29M
Baker bros. advisors lp42.90M8.98%$925.28M
Stonepine capital management225.00K4.76%$4.85M
Birchview capital, lp187.80K4.02%$4.05M
Nan fung group102.98K3.50%$2.22M
Rtw investments, lp9.00M2.76%$194.03M
Tang capital management1.50M1.64%$32.35M
Jgp global gestao de recursos ltda.34.62K1.45%$635.28M
Sphera funds management174.90K0.89%$3.77M
Rice hall james & associates669.81K0.78%$14.45M

Top Buyers

HolderShares% AssetsChange
Marshall wace, llp1.97M0.05%1.64M
Citigroup1.67M0.02%1.55M
Norges bank1.39M0.00%1.39M
Jacobs levy equity management1.36M0.09%1.36M
Pictet asset management sa1.58M0.04%1.15M

Top Sellers

HolderShares% AssetsChange
Assenagon asset management1.71M0.05%-1.95M
Point72 asset management3.17M0.13%-1.48M
State street4.52M0.00%-1.45M
Ecor1 capital---1.35M
Millennium management1.12M0.01%-934.76K

New Positions

HolderShares% AssetsChangeValue
Norges bank1.39M0.00%1.39M$25.55M
Adage capital partners gp603.80K0.02%603.80K$13.02M
Arrowstreet capital, limited partnership336.44K0.01%336.44K$7.26M
J. goldman & co lp164.28K0.08%164.28K$3.54M
Readystate asset management lp92.00K0.06%92.00K$1.98M

Sold Out

HolderChange
Coppell advisory solutions-4.00
Concord wealth partners-10.00
Huntington national bank-12.00
Advisornet financial-12.00
Bokf, na-16.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 2025321-3.02%169,479,977-1.03%1000.96%143-12.80%12318.27%
Mar 31, 20253298.94%171,281,5815.19%1021.07%163-8.94%10341.10%
Dec 31, 20242949.70%162,117,2274.78%971.12%17134.65%74-7.50%
Sep 30, 2024266-3.97%154,699,805-3.89%930.99%127-15.89%801.27%
Jun 30, 2024275-4.51%160,951,1580.75%971.04%150-3.23%785.41%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
iShares Core S&P Small-Cap ETF7.41M4.39%1.10K
Vanguard Total Stock Mkt Idx Inv3.94M2.34%-84.41K
Vanguard US Total Market Shares ETF3.89M2.33%4.42K
Vanguard Small Cap Index3.05M1.81%-19.99K
iShares Russell 2000 ETF2.93M1.74%-55.65K
Vanguard Small Cap Growth Index Inv1.72M1.02%-638.00
First Trust NYSE Arca Biotech ETF1.65M0.99%-
SPDR® S&P Biotech ETF1.53M0.91%37.62K
Vanguard Institutional Extnd Mkt Idx Tr1.33M0.79%-579.67K
Fidelity Small Cap Index1.25M0.74%35.09K

Recent Insider Transactions


DateNameRoleActivityValue
Sep 15, 2025Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICERSell$82.73K
Sep 02, 2025GAROFALO ELIZABETH A.-Sell$41.56K
Aug 18, 2025Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICERSell$554.02K
Jun 04, 2025Brege Laura-Sell$314.63K
May 16, 2025Kihara James PRINCIPAL ACCOUNTING OFFICERSell$50.00K

Insider Transactions Trends


DateBuySell
2025 Q3-3
2025 Q2-8
2025 Q1-5
2024 Q4-3
2024 Q3-3

ACAD Ownership FAQ


Who Owns ACADIA Pharmaceuticals?

ACADIA Pharmaceuticals shareholders are primarily institutional investors at 100.98%, followed by 0.57% insiders and -1.55% retail investors. The average institutional ownership in ACADIA Pharmaceuticals's industry, Biotech Stocks , is 306.59%, which ACADIA Pharmaceuticals falls below.

Who owns the most shares of ACADIA Pharmaceuticals?

ACADIA Pharmaceuticals’s largest shareholders are Baker bros. advisors lp (42.9M shares, 25.56%), Blackrock funding, inc. /de (20.65M shares, 12.31%), and Vanguard group (13.95M shares, 8.40%). Together, they hold 46.27% of ACADIA Pharmaceuticals’s total shares outstanding.

Does Blackrock own ACADIA Pharmaceuticals?

Yes, BlackRock owns 7.32% of ACADIA Pharmaceuticals, totaling 12.06M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 196.01M$. In the last quarter, BlackRock increased its holdings by 393.47K shares, a 3.37% change.

Who is ACADIA Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Palo alto investors lp is ACADIA Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 11.76% of its assets in 2.56M ACADIA Pharmaceuticals shares, valued at 55.29M$.

Who is the top mutual fund holder of ACADIA Pharmaceuticals shares?

iShares Core S&P Small-Cap ETF is the top mutual fund holder of ACADIA Pharmaceuticals shares, with 4.39% of its total shares outstanding invested in 7.41M ACADIA Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools